Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound

August 27, 2025 

Next-generation 2D and 3D imaging and intelligent automation empower clinicians to make faster, more confident decisions in cardiac care

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the release of Transcend Plus, the next generation its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transcend Plus delivers major advancements in image quality and artificial intelligence (AI), including newly FDA-cleared 2D and 3D image quality enhancements and a growing suite of AI-enabled clinical applications – all designed to meet the growing challenges of cardiac care delivery. With increased patient volume, rising clinical complexity, and persistent staffing shortages, Transcend Plus is designed to help cardiology teams work smarter, not harder – offering fast, reproducible results with uncompromising image quality and decision-making support.

Read more at globenewswire.com